Frederick W. Gergits

2.5k total citations · 1 hit paper
6 papers, 1.4k citations indexed

About

Frederick W. Gergits is a scholar working on Neurology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Frederick W. Gergits has authored 6 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 5 papers in Immunology and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in Frederick W. Gergits's work include Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Inflammation biomarkers and pathways (4 papers) and Immune cells in cancer (2 papers). Frederick W. Gergits is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Inflammation biomarkers and pathways (4 papers) and Immune cells in cancer (2 papers). Frederick W. Gergits collaborates with scholars based in United States, Singapore and United Kingdom. Frederick W. Gergits's co-authors include Beth Stevens, Stefanie Giera, Connor Dufort, Robin J.M. Franklin, Alec Wysoker, Evan Z. Macosko, Samuel E. Marsh, Jinmiao Chen, Steven A. McCarroll and Xianhua Piao and has published in prestigious journals such as Nature Medicine, Immunity and Neurology.

In The Last Decade

Frederick W. Gergits

5 papers receiving 1.4k citations

Hit Papers

Single-Cell RNA Sequencing of Microglia throughout the Mo... 2018 2026 2020 2023 2018 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick W. Gergits United States 5 1.2k 653 363 202 201 6 1.4k
Connor Dufort United States 4 1.1k 1.0× 652 1.0× 354 1.0× 194 1.0× 166 0.8× 4 1.4k
Bernice Matusow United States 5 1.2k 1.0× 584 0.9× 210 0.6× 230 1.1× 226 1.1× 13 1.4k
Julia Bruttger Germany 7 1.1k 0.9× 671 1.0× 216 0.6× 186 0.9× 163 0.8× 10 1.4k
Kathleen Grabert Sweden 10 918 0.8× 510 0.8× 273 0.8× 233 1.2× 167 0.8× 16 1.2k
Marta Olah United States 17 1.0k 0.9× 609 0.9× 450 1.2× 393 1.9× 190 0.9× 25 1.7k
Moumita Datta Germany 11 858 0.7× 636 1.0× 277 0.8× 175 0.9× 154 0.8× 16 1.2k
Zain Fanek United States 3 1.7k 1.5× 1.0k 1.6× 495 1.4× 381 1.9× 228 1.1× 6 2.2k
José L. Marín‐Teva Spain 19 1.2k 1.0× 557 0.9× 489 1.3× 144 0.7× 288 1.4× 32 1.7k
Lindsay A. Hohsfield United States 15 699 0.6× 301 0.5× 229 0.6× 315 1.6× 196 1.0× 23 1.1k
Anna Michel Germany 9 717 0.6× 443 0.7× 243 0.7× 153 0.8× 142 0.7× 30 1.1k

Countries citing papers authored by Frederick W. Gergits

Since Specialization
Citations

This map shows the geographic impact of Frederick W. Gergits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick W. Gergits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick W. Gergits more than expected).

Fields of papers citing papers by Frederick W. Gergits

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick W. Gergits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick W. Gergits. The network helps show where Frederick W. Gergits may publish in the future.

Co-authorship network of co-authors of Frederick W. Gergits

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick W. Gergits. A scholar is included among the top collaborators of Frederick W. Gergits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick W. Gergits. Frederick W. Gergits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Gergits, Frederick W., Abigail J. Renoux, Borislav Dejanovic, et al.. (2025). Rescue of in vitro models of CSF1R-related adult-onset leukodystrophy by iluzanebart: mechanisms and therapeutic implications of TREM2 agonism. Journal of Neuroinflammation. 22(1). 26–26. 4 indexed citations
2.
Mirescu, Christian, Borislav Dejanovic, Frederick W. Gergits, et al.. (2024). Pharmacological and functional characterization of the first small molecule TREM2 agonist, VG‐3927, for the treatment of Alzheimer’s disease. Alzheimer s & Dementia. 20(S6). 4 indexed citations
3.
Gergits, Frederick W., Abigail J. Renoux, Borislav Dejanovic, et al.. (2024). VGL101: An Immunotherapy that Enhances Microglial Survival for Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) (P9-9.013). Neurology. 102(7_supplement_1).
4.
Wilton, Daniel K., Kevin Mastro, Frederick W. Gergits, et al.. (2023). Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington’s disease. Nature Medicine. 29(11). 2866–2884. 79 indexed citations
5.
Gergits, Frederick W., Abigail J. Renoux, Matthew D. Figley, et al.. (2022). VGL101 Rescues CSF1R Dysfunction in Human Microglia And Macrophages: Evaluation of In Vitro Trem2 Agonism in Models Of A CSF1R‐Dependent Leukodystrophy. Alzheimer s & Dementia. 18(S3). 4 indexed citations
6.
Hammond, Timothy R., Connor Dufort, Lasse Dissing‐Olesen, et al.. (2018). Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity. 50(1). 253–271.e6. 1359 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026